ProfileGDS4459 / ENSG00000168944
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 85% 87% 84% 77% 86% 83% 83% 86% 84% 80% 83% 84% 83% 84% 84% 82% 85% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.4285
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.6287
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.6284
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.6477
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.8486
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.3983
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.583
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.7886
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.6684
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.1780
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.4283
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.6484
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.4183
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.2784
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.6184
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.182
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.5585